Data Marketing Partnership Wins Right to Skirt ACA Rules, Reshaping How Millions Shop For Coverage

A lawsuit that started in 2019 is about to reshape how health plans define "employee", and the implications for healthcare marketers are stark. Court papers filed in September 2026 indicate a settlement may be imminent in Data Marketing Partnership v. Department of Labor, a case that could legitimize a category of workplace health plans that avoid Affordable Care Act benefit requirements and state insurance oversight . The timing creates a perfect storm: millions dropped ACA marketplace coverage in 2026 as premiums surged after Congress let enhanced subsidies expire, creating a massive pool of cost-sensitive consumers hunting for alternatives [1,2]. If the Department of Labor reverses its position and recognizes limited partners as employees, expect aggressive marketing of plans that look like employer coverage but function more like short-term insurance.

The business model is straightforward: a consumer downloads software that tracks internet searches, becomes a "limited partner" in an organization like Data Marketing Partnership, then gains access to group health plans exempt from state rules and ACA essential health benefit mandates . A Texas district court already ruled in the company's favor in 2020, calling the Labor Department's rejection of this arrangement "arbitrary and capricious," and the Fifth Circuit largely upheld that decision . What remains unresolved is whether downloading software makes someone a "working owner" or "bona fide partner", questions the lower court was ordered to reconsider.

Katie Keith, director of the Center for Health Policy and the Law at Georgetown University Law Center, warned that a settlement favoring the plaintiff "could be an even bigger expansion" than the Trump administration's push for short-term plans . The verdict matters beyond one company: it establishes whether data brokers, supplement sellers, and other entities can bundle insurance access with nominal work arrangements, creating what Ali Khawar, former principal deputy assistant secretary at the Employee Benefits Security Administration, called "functionally, unregulated insurance companies" . For healthcare marketers, this opens distribution channels that bypass traditional broker networks and state insurance departments, but also creates compliance minefields and reputational risks.

The ERISA Exemption That Changes Everything

The case hinges on the Employee Retirement Income Security Act of 1974, which allows large self-insured employers to offer health benefits without meeting state-by-state insurance rules . ERISA was designed for legitimate employer plans, think Fortune 500 companies with thousands of workers. But Data Marketing Partnership argues its limited partners qualify as employees, giving the company ERISA's regulatory shield. If that interpretation stands, the coverage avoids state insurance commissioner oversight, doesn't have to cover the 10 categories of essential health benefits required under the ACA, and operates in a regulatory gray zone where consumer complaints have limited recourse.

State insurance commissioners have been fighting this model aggressively. Maryland fined The Vitamin Patch in 2024 for offering limited-partnership insurance without a license . Washington ordered another company to stop selling these plans in 2021 and imposed a $25,000 fine . Maine and Connecticut issued consumer warnings in 2024 about entities including Affiliated Workers Alliance, Consumer Data Partners, Employers Business Alliance, Socios Buenos, and Strategic Limited Partners . Connecticut's notice bluntly stated: "These plans do not provide comprehensive medical coverage and can leave consumers with large, unpaid medical bills" .

But state enforcement becomes nearly impossible if the Department of Labor settles and grants these arrangements legitimacy. State insurance commissioners filed legal briefs arguing the case threatens their ability to protect consumers. Maryland Insurance Commissioner Marie Grant said: "If the case goes the wrong way, it could impact consumers or hamstring the states" . The money at stake is significant. Self-insured employer plans managed $969 billion in assets in 2024, and even capturing a small percentage of ACA marketplace enrollees, which totaled roughly 16 million before the 2026 premium spikes, represents billions in premium revenue outside traditional regulatory structures.

The ACA Premium Crisis Creates Demand

The demand for alternatives is real and growing. In Georgia's 14th Congressional District, 74,000 people relied on enhanced ACA subsidies before they expired at the end of 2025 . Amber Bates of Cohutta, Georgia, watched her mother-in-law drop ACA coverage after subsidies ended. The family, which includes a 2-year-old and a child with autism, now spends about one-third of household income on prescription drugs and uses emergency rooms for primary care because they aren't billed upfront . Bates and her husband earn too much for Medicaid but can't afford unsubsidized marketplace plans. The 14th District is Georgia's most conservative, yet even Trump loyalists like Bates are questioning whether the administration is addressing healthcare costs .

Insurers are requesting double-digit ACA premium increases for 2027, partly because healthier enrollees are leaving the marketplaces . This creates adverse selection: as premiums rise, healthier people drop coverage, leaving a sicker risk pool that drives premiums higher still. Limited-partnership plans could accelerate this cycle. They appeal to younger, healthier consumers willing to accept narrower benefits in exchange for lower premiums. That pulls low-risk enrollees out of ACA plans, worsening the risk pool and justifying further premium increases.

For healthcare marketers, this creates strategic tension. Limited-partnership plans offer a new patient acquisition channel with potentially lower customer acquisition costs: these companies market directly to consumers online, bypassing broker commissions. But the plans also attract price-sensitive, potentially healthier patients who might otherwise enter your system through employer plans or ACA exchanges. If your health system relies on ACA exchange partnerships or employer contracts, limited-partnership plans represent competitive threats. If you're exploring direct-to-consumer strategies, they represent a regulatory workaround that may or may not survive legal scrutiny.

What Marketers Need to Watch

Compliance Considerations

ERISA exemption means limited-partnership plans avoid state insurance department oversight, but they don't escape all regulation. The Department of Labor's Employee Benefits Security Administration oversees ERISA plans, though its enforcement resources are stretched thin across thousands of employer plans . The Federal Trade Commission retains authority over deceptive marketing practices. Any healthcare marketer promoting limited-partnership plans must ensure advertising doesn't overstate benefits or mislead consumers about coverage limitations.

HIPAA business associate agreements still apply. If your health system shares patient data with a limited-partnership insurer for claims processing or care coordination, standard privacy protections remain in force. But consumer recourse is limited. Patients who dispute claim denials in ERISA plans face federal appeals processes that are slower and more complex than state insurance department complaints.

State consumer protection laws may still apply to the marketing of these plans, even if the plans themselves avoid insurance regulation. Connecticut's 2024 warning noted that "these plans do not provide comprehensive medical coverage and can leave consumers with large, unpaid medical bills" . Any healthcare entity whose brand appears in conjunction with these plans (through advertising partnerships, provider directories, or co-marketing) risks reputational damage if consumers experience coverage gaps.

The 1ness Take

Healthcare marketers face a choice: participate in the limited-partnership insurance ecosystem or prepare to compete against it. Neither option is simple.

The case for engagement: these plans will capture market share regardless of your participation. Data Marketing Partnership and similar entities already operate in multiple states despite regulatory pushback. A settlement legitimizing their model will accelerate growth. Health systems that establish network relationships now can negotiate rates proactively rather than dealing with reference-based pricing or patient balance bills after the fact. Marketing partnerships, if structured carefully, could drive patient volume from younger, commercially insured populations that many systems struggle to attract.

The case for distance: limited-partnership plans undermine insurance risk pooling and shift costs to providers and patients. The business model depends on information asymmetry, consumers who don't fully understand coverage limitations until they need care. Any health system whose mission includes community health or health equity should question whether these plans advance or undermine those goals. The regulatory foundation remains unstable. Even a favorable settlement could face legislative reversal if premium increases drive political pressure or if states find new enforcement mechanisms.

Our recommendation: monitor but don't commit. Assign someone on your team to track the settlement terms when announced. Conduct a state-by-state analysis of where your system operates and what enforcement actions those states have taken. Model the financial impact if 10%, then 20% of your commercially insured patients shift to limited-partnership plans with narrower networks or reference-based pricing. Prepare your revenue cycle team to identify these plans at registration and verify benefits before service delivery.

If you choose to participate in networks for these plans, negotiate rates explicitly, don't accept reference-based pricing or Medicare-plus formulas without modeling the reimbursement impact. If you choose to advertise or co-market with limited-partnership insurers, ensure legal review of all materials and maintain editorial control over how your brand appears. Document coverage limitations clearly in any patient-facing communications.

The broader strategic question: what does it mean for your market if healthy, price-sensitive consumers migrate to limited-partnership plans while sicker, higher-cost patients remain in ACA exchanges with rising premiums? This dynamic could accelerate insurance market segmentation and concentrate high-need patients in Medicaid and subsidized ACA plans. Health systems with meaningful ACA exchange volume or Medicaid contracts need to plan for worsening risk pools and potentially higher uncompensated care as patients discover coverage gaps mid-treatment.

The Takeaway

The Data Marketing Partnership settlement will determine whether downloading software to track internet searches counts as employment for health insurance purposes. That legal technicality has massive practical implications: it could legitimize a new category of health plans that avoid state oversight and ACA benefit requirements, just as millions of Americans are dropping coverage due to premium increases.

• Assign monitoring responsibility: Designate someone to track the settlement terms when announced and analyze implications for your markets and payer mix.

• Assess financial exposure: Model revenue impact if 10-20% of commercial patients shift to plans using reference-based pricing or narrow networks. Identify service lines most vulnerable to reimbursement pressure.

• Prepare operational responses: Train registration and revenue cycle staff to identify limited-partnership plans, verify benefits proactively, and set patient payment expectations before service delivery. Update financial counseling scripts to address coverage gaps these plans may contain.

The Department of Labor's decision will arrive during a volatile period for health insurance markets. Premium increases, subsidy expirations, and regulatory changes are pushing consumers toward alternatives. Whether those alternatives provide adequate protection or simply shift financial risk to patients and providers remains the central question, and the answer will shape healthcare marketing strategy for years to come.